- Pharmaceutical companies
- Chiesi Farmaceutici
Chiesi Farmaceutici
Phone: +39 5212791
Type | Società per Azioni, (S.p.A.) (something like a Joint-Stock company) |
---|---|
Industry | Pharmaceuticals |
Founded | 1935 |
Headquarters | Parma, Italy |
Key people | Alberto Chiesi (President) Paolo Chiesi (Vice-president) Ugo Di Francesco (CEO) |
Revenue | €2.229 billion (2020) |
Number of employees | 6389 |
Website | www.chiesi.com |
We want to be recognized as an international group focused on research, able to develop and commercialize innovative therapeutic solutions that improve people's quality of life. We intend to maintain a high quality entrepreneurial team, characterized by a spirit of collaboration and self-confidence. Our goal is to combine commitment to results and integrity, operating with responsibility both from a social and an environmental point of view.
For detailed contact information visit location pages below.
Chiesi Farmaceutici's locations around the world
Europe
North America
South America
Oceania
Clinical Trials sponsored by Chiesi Farmaceutici
-
Chiesi ItaliaActivo, no reclutando
-
Chiesi Farmaceutici S.p.A.ReclutamientoAfección pulmonar obstructiva crónicaBulgaria, Estados Unidos, Albania, Argentina, Australia, Austria, Bosnia y Herzegovina, Chile, Porcelana, Chequia, Georgia, Alemania, Grecia, Hungría, Israel, Italia, México, Países Bajos, Nueva Zelanda, Macedonia del norte, Polonia, Rumani... y más
-
Chiesi Farmaceutici S.p.A.Activo, no reclutando
-
Chiesi Farmaceutici S.p.A.TerminadoTrombosis | Oclusión del catéterEstados Unidos, Argentina, Bélgica, Chequia, Polonia, Rumania, España
-
Chiesi Farmaceutici S.p.A.TerminadoLamazym Aftercare Study FR diseñado para proporcionar tratamiento a pacientes franceses (rhLAMAN-07)Alfa-manosidosisFrancia
-
Chiesi Farmaceutici S.p.A.TerminadoSíndrome de distrés respiratorio agudoEstados Unidos, Italia, Reino Unido
-
Chiesi Farmaceutici S.p.A.Activo, no reclutandoEnfermedad de FabryBélgica, Estados Unidos, Reino Unido, Italia, Chequia, Dinamarca, Noruega
-
Chiesi Farmaceutici S.p.A.TerminadoObstrucción parcial de la derivación de la arteria sistémica a la pulmonar | Obstrucción completa de la derivación de la arteria sistémica a la pulmonarEstados Unidos
-
Chiesi Farmaceutici S.p.A.Terminado